Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sysbiotech is an Austrian bioprocess equipment and automation company serving biotechnology, biopharma, vaccine, agriculture, and related industrial customers. The company designs and manufactures fermentation and cell culture systems, including lab-, pilot-, and industrial-scale bioreactors and fermenters, along with CIP, filtration, separation, and freeze-drying solutions. It also provides end-to-end project support spanning design, installation, qualification, validation, and retrofitting of existing process equipment. A notable element of its offering is the proprietary C-BIO software control platform for centralized control and integration of multiple fermenters, bioreactors, and other process equipment. Sysbiotech appears to be a commercial-stage supplier rather than a therapeutic drug developer, with offerings focused on process infrastructure and manufacturing support.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sysbiotech.